Licensing through New Directions Technology Consulting, LLC
The technology protected by the five issued patents in the mMed patent portfolio could significantly advance medication management, including the delivery of essential medical information not communicated today. These “mHealth” patents were filed beginning in 2006 and issued by the USPTO between July 2010 and July 2012.
mHealth is the use of mobile and wireless devices to improve health outcomes, healthcare services and health research.
The definition was developed by a National Institutes of Health (NIH) Consensus group; the NIH is an agency of the U.S. Department of Health and Human Services.
New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio, which relates to technology that takes a comprehensive medication management program into “the wild,” wherever mobile patients are. New Directions can license the intellectual property or partner to develop a mobile medication management system based on the patents.